AA
ALPS Advisors Portfolio holdings
AUM
$17.3B
1-Year Return
13.43%
This Quarter Return
+11.67%
1 Year Return
+13.43%
3 Year Return
+69.62%
5 Year Return
+161.48%
10 Year Return
+94.79%
AUM
$9.22B
AUM Growth
+$331M
(+3.7%)
Cap. Flow
-$367M
Cap. Flow
% of AUM
-3.98%
Top 10 Holdings %
Top 10 Hldgs %
56.36%
Holding
1,043
New
155
Increased
182
Reduced
486
Closed
210
Top Buys
| 1 |
Hess Midstream
HESM
|
$148M |
| 2 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
$106M |
| 3 |
CEQP
Crestwood Equity Partners LP
CEQP
|
$99.9M |
| 4 |
MPLX
MPLX
|
$76.6M |
| 5 |
Energy Transfer Partners
ET
|
$70.9M |
Top Sells
| 1 |
Western Midstream Partners
WES
|
$541M |
| 2 |
PSXP
PHILLIPS 66 PARTNERS LP
PSXP
|
$338M |
| 3 |
Williams Companies
WMB
|
$39.2M |
| 4 |
Exxon Mobil
XOM
|
$31.4M |
| 5 |
Verizon
VZ
|
$24.2M |
Sector Composition
| 1 | Energy | 65.72% |
| 2 | Technology | 5.09% |
| 3 | Consumer Discretionary | 3.8% |
| 4 | Healthcare | 3.45% |
| 5 | Industrials | 3.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Sabra Healthcare REIT
SBRA
$4.56B
| $1.13M | 0.01% |
75,602
-11,641
| -13% | -$173K |
|
302
Omega Healthcare
OHI
$12.7B
| $1.11M | 0.01% |
35,461
-5,070
| -13% | -$158K |
|
303
National Health Investors
NHI
$3.72B
| $1.09M | 0.01% |
18,418
-2,834
| -13% | -$167K |
|
304
Marriott International Class A Common Stock
MAR
$71.9B
| $1.08M | 0.01% |
6,151
+2,695
| +78% | +$474K |
|
|
IMGN
305
DELISTED
Immunogen Inc
IMGN
| $1.08M | 0.01% |
226,649
-21,110
| -9% | -$100K |
|
306
Crinetics Pharmaceuticals
CRNX
$3.35B
| $1.07M | 0.01% |
48,815
-6,149
| -11% | -$135K |
|
307
Rocket Pharmaceuticals
RCKT
$354M
| $1.05M | 0.01% |
66,294
-8,283
| -11% | -$131K |
|
|
RC
308
Ready Capital
RC
$705M
| $1.04M | 0.01% |
68,749
-8,701
| -11% | -$131K |
|
309
SiriusXM
SIRI
$8.1B
| $1.03M | 0.01% |
15,620
-2,529
| -14% | -$167K |
|
310
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $1.03M | 0.01% |
79,420
-9,439
| -11% | -$122K |
|
311
Organogenesis Holdings
ORGO
$634M
| $1.01M | 0.01% |
132,342
-41,994
| -24% | -$320K |
|
|
PMT
312
PennyMac Mortgage Investment
PMT
$1.1B
| $1.01M | 0.01% |
59,521
-7,536
| -11% | -$127K |
|
313
Advanced Micro Devices
AMD
$245B
| $1M | 0.01% |
9,140
-1,256
| -12% | -$137K |
|
314
Arcutis Biotherapeutics
ARQT
$2.06B
| $997K | 0.01% |
51,783
-6,420
| -11% | -$124K |
|
315
Syndax Pharmaceuticals
SNDX
$1.47B
| $983K | 0.01% |
56,536
-1,643
| -3% | -$28.6K |
|
316
Anavex Life Sciences
AVXL
$807M
| $964K | 0.01% |
78,286
-9,686
| -11% | -$119K |
|
317
MannKind Corp
MNKD
$1.7B
| $952K | 0.01% |
258,787
-31,997
| -11% | -$118K |
|
318
Annaly Capital Management
NLY
$14.2B
| $923K | 0.01% |
32,782
-4,150
| -11% | -$117K |
|
319
Blue Owl Capital
OBDC
$7.33B
| $909K | 0.01% |
+61,500
| New | +$909K |
|
320
Cintas
CTAS
$82.4B
| $900K | 0.01% |
8,468
+3,340
| +65% | +$355K |
|
321
The Mosaic Company
MOS
$10.3B
| $894K | 0.01% |
13,455
-5,372
| -29% | -$357K |
|
322
Atara Biotherapeutics
ATRA
$90.7M
| $889K | 0.01% |
3,827
-266
| -6% | -$61.8K |
|
|
KDNY
323
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $889K | 0.01% |
54,364
-6,857
| -11% | -$112K |
|
324
Estee Lauder
EL
$32.1B
| $884K | 0.01% |
3,248
+236
| +8% | +$64.2K |
|
|
RTLR
325
DELISTED
Rattler Midstream LP Common Units
RTLR
| $878K | 0.01% |
62,815
-4,168
| -6% | -$58.3K |
|